Pituitary hormonal loss and recovery after transsphenoidal adenoma removal

Neurosurgery

Volumn 63, Issue 4, 2008, Pages 709-718

  Fatemi, Nasrin ^a   Dusick, Joshua R ^b   Mattozo, Carlos ^b   McArthur, David L ^b   Cohan, Pejman ^c   Boscardin, John ^b   Wang, Christina ^c   Swerdloff, Ronald S ^c   Kelly, Daniel F ^a,d  

^a JOHN WAYNE CANCER INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HARBOR UCLA MEDICAL CENTER   (United States)

^d Brain Tumor Center   (United States)

Author keywords

Endonasal surgery; Hyperprolactinemia; Hypopituitarism; Pituitary adenoma; Pituitary hormonal function; Transsphenoidal surgery

Indexed keywords

HYPOPHYSIS HORMONE;

ADULT; ARTICLE; DIABETES INSIPIDUS; ENDOCRINE DISEASE; FEMALE; FOLLOW UP; HORMONE ACTION; HORMONE BLOOD LEVEL; HUMAN; HYPERPROLACTINEMIA; HYPOGONADISM; HYPOPHYSIS ADENOMA; HYPOPITUITARISM; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE CARE; PRIORITY JOURNAL; SELLA TURCICA TUMOR; TRANSSPHENOIDAL HYPOPHYSECTOMY; TRANSSPHENOIDAL SURGERY; TUMOR VOLUME;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CHILD; FEMALE; HUMANS; HYPOPITUITARISM; MALE; MIDDLE AGED; NEUROSURGICAL PROCEDURES; PITUITARY HORMONES; PITUITARY NEOPLASMS; PREDICTIVE VALUE OF TESTS; RECOVERY OF FUNCTION; SPHENOID BONE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 56749153620     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000325725.77132.90     Document Type: Article

References (50)

1. Abosch A, Tyrrell JB, Lamborn KR, Hannegan LT, Applebury CB, Wilson CB: Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: Initial outcome and long-term results. J Clin Endocrinol Metab 83:3411-3418, 1998.
2. Aimaretti G, Baldelli R, Corneli G, Croce C, Rovere S, Baffoni C, Bellone S, Gasco S, Granata R, Grottoli S, Ghigo E: IGFs and IGFBPs in adult growth hormone deficiency. Endocr Dev 9:76-88, 2005.
3. Aimaretti G, Corneli G, Baldelli R, Di Somma C, Gasco V, Durante C, Ausiello L, Rovere S, Grottoli S, Tamburrano G, Ghigo E: Diagnostic reliability of a single IGF-I measurement in 237 adults with total anterior hypopituitarism and severe GH deficiency. Clin Endocrinol (Oxf) 59:56-61, 2003.
4. Aimaretti G, Corneli G, Di Somma C, Baldelli R, Gasco V, Rovere S, Migliaretti G, Colao A, Tamburrano G, Lombardi G, Ghigo E, Camanni F: Different degrees of GH deficiency evidenced by GHRH+arginine test and IGF-I levels in adults with pituitary disease. J Endocrinol Invest 28:247-252, 2005.
5. Arafah BM: Reversible hypopituitarism in patients with large nonfunctioning pituitary adenomas. J Clin Endocrinol Metab 62:1173-1179, 1986.
6. Arafah BM, Kailani SH, Nekl KE, Gold RS, Selman WR: Immediate recovery of pituitary function after transsphenoidal resection of pituitary macroadenomas. J Clin Endocrinol Metab 79:348-354, 1994.
7. Arafah BM, Prunty D, Ybarra J, Hlavin ML, Selman WR: The dominant role of increased intrasellar pressure in the pathogenesis of hypopituitarism, hyperprolactinemia, and headaches in patients with pituitary adenomas. J Clin Endocrinol Metab 85:1789-1793, 2000.
8. Auer LM, Clarici G: The first 100 transsphenoidally operated pituitary adenomas in a non-specialised centre: Surgical results and tumour-recurrence. Neurol Res 7:153-160, 1985.
9. Barker FG 2nd, Klibanski A, Swearingen B: Transsphenoidal surgery for pituitary tumors in the United States, 1996-2000: Mortality, morbidity, and the effects of hospital and surgeon volume. J Clin Endocrinol Metab 88:4709-4719, 2003.
10. Black PM, Zervas NT, Candia GL: Incidence and management of complications of transsphenoidal operation for pituitary adenomas. Neurosurgery 20:920-924, 1987.
11. Brand IR, Dalton GA, Fletcher RF: Long-term follow up of trans-sphenoidal hypophysectomy for Cushing's disease. J R Soc Med 78:291-293, 1985.
12. Cappabianca P, Cavallo LM, Colao A, de Divitiis E: Surgical complications associated with the endoscopic endonasal transsphenoidal approach for pituitary adenomas. J Neurosurg 97:293-298, 2002.
13. Chee GH, Mathias DB, James RA, Kendall-Taylor P: Transsphenoidal pituitary surgery in Cushing's disease: Can we predict outcome? Clin Endocrinol (Oxf) 54:617-626, 2001.
14. Chen JC, Amar AP, Choi S, Singer P, Couldwell WT, Weiss MH: Transsphenoidal microsurgical treatment of Cushing disease: Postoperative assessment of surgical efficacy by application of an overnight low-dose dexamethasone suppression test. J Neurosurg 98:967-973, 2003.
15. Ciric I, Ragin A, Baumgartner C, Pierce D: Complications of transsphenoidal surgery: Results of a national survey, review of the literature, and personal experience. Neurosurgery 40:225-237, 1997.
16. Clemmons DR: Clinical utility of measurements of insulin-like growth factor 1. Nat Clin Pract Endocrinol Metab 2:436-446, 2006.
17. Colao A, Cerbone G, Cappabianca P, Ferone D, Alfieri A, Di Salle F, Faggiano A, Merola B, de Divitiis E, Lombardi G: Effect of surgery and radiotherapy on visual and endocrine function in nonfunctioning pituitary adenomas. J Endocrinol Invest 21:284-290, 1998.
18. Comtois R, Beauregard H, Somma M, Serri O, Aris-Jilwan N, Hardy J: The clinical and endocrine outcome to trans-sphenoidal microsurgery of nonsecreting pituitary adenomas. Cancer 68:860-866, 1991.
19. De P, Rees DA, Davies N, John R, Neal J, Mills RG, Vafidis J, Davies JS, Scanlon MF: Transsphenoidal surgery for acromegaly in Wales: Results based on stringent criteria of remission. J Clin Endocrinol Metab 88:3567-3572, 2003.
20. Esposito F, Dusick JR, Cohan P, Moftakhar P, McArthur D, Wang C, Swerdloff RS, Kelly DF: Clinical review: Early morning cortisol levels as a predictor of remission after transsphenoidal surgery for Cushing's disease. J Clin Endocrinol Metab 91:7-13, 2006.
21. Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnell CD, Culebras A, DeGraba TJ, Gorelick PB, Guyton JR, Hart RG, Howard G, Kelly-Hayes M, Nixon JV, Sacco RL; American Heart Association; American Stroke Association Stroke Council: Primary prevention of ischemic stroke: A guideline from the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 113:e873-e923, 2006.
22. Gorczyca W, Hardy J: Arterial supply of the human anterior pituitary gland. Neurosurgery 20:369-378, 1987.
23. Greenman Y, Tordjman K, Kisch E, Razon N, Ouaknine G, Stern N: Relative sparing of anterior pituitary function in patients with growth hormone-secreting macroadenomas: Comparison with nonfunctioning macroadenomas. J Clin Endocrinol Metab 80:1577-1583, 1995.
24. Hammer GD, Tyrrell JB, Lamborn KR, Applebury CB, Hannegan ET, Bell S, Rahl R, Lu A, Wilson CB: Transsphenoidal microsurgery for Cushing's disease: Initial outcome and long-term results. J Clin Endocrinol Metab 89:6348-6357, 2004.
25. Hensen J, Henig A, Fahlbusch R, Meyer M, Boehnert M, Buchfelder M: Prevalence, predictors and patterns of postoperative polyuria and hyponatraemia in the immediate course after transsphenoidal surgery for pituitary adenomas. Clin Endocrinol (Oxf) 50:431-439, 1999.
26. Hoffman DM, O'Sullivan AJ, Baxter RC, Ho KK: Diagnosis of growth-hormone deficiency in adults. Lancet 343:1064-1068, 1994.
27. Kelly DF, Laws ER Jr, Fossett D: Delayed hyponatremia after transsphenoidal surgery for pituitary adenoma. Report of nine cases. J Neurosurg 83:363-367, 1995.
28. Kruse A, Astrup J, Gyldensted C, Cold GE: Hyperprolactinaemia in patients with pituitary adenomas. The pituitary stalk compression syndrome. Br J Neurosurg 9:453-457, 1995.
29. Lees PD, Pickard JD: Hyperprolactinemia, intrasellar pituitary tissue pressure, and the pituitary stalk compression syndrome. J Neurosurg 67:192-196, 1987.
30. Lees PD, Fahlbusch R, Zrinzo A, Pickard JD: Intrasellar pituitary tissue pressure, tumour size and endocrine status - An international comparison in 107 patients. Br J Neurosurg 8:313-318, 1994.
31. Littley MD, Shalet SM, Beardwell CG, Ahmed SR, Sutton ML: Long-term follow-up of low-dose external pituitary irradiation for Cushing's disease. Clin Endocrinol (Oxf) 33:445-455, 1990.
32. Marazuela M, Astigarraga B, Vicente A, Estrada J, Cuerda C, García-Uría J, Lucas T: Recovery of visual and endocrine function following transsphenoidal surgery of large nonfunctioning pituitary adenomas. J Endocrinol Invest 17:703-707, 1994.
33. Mattozo CA, Dusick JR, Esposito F, Mora H, Cohan P, Malkasian D, Kelly DF: Suboptimal sphenoid and sellar exposure: A consistent finding in patients treated with repeat transsphenoidal surgery for residual endocrine-inactive macroadenomas. Neurosurgery 58:857-865, 2006.
34. McCance DR, Gordon DS, Fannin TF, Hadden DR, Kennedy L, Sheridan B, Atkinson AB: Assessment of endocrine function after transsphenoidal surgery for Cushing's disease. Clin Endocrinol (Oxf) 38:79-86, 1993.
35. Mesiwala AH, Farrell L, Santiago P, Ghatan S, Silbergeld DL: The effects of hydrogen peroxide on brain and brain tumors. Surg Neurol 59:398-407, 2003.
36. Nelson AT Jr, Tucker HS Jr, Becker DP: Residual anterior pituitary function following transsphenoidal resection of pituitary macroadenomas. J Neurosurg 61:577-580, 1984.
37. Nemergut EC, Zuo Z, Jane JA Jr, Laws ER Jr: Predictors of diabetes insipidus after transsphenoidal surgery: A review of 881 patients. J Neurosurg 103:448-454, 2005.
38. Nomikos P, Ladar C, Fahlbusch R, Buchfelder M: Impact of primary surgery on pituitary function in patients with non-functioning pituitary adenomas - A study on 721 patients. Acta Neurochir (Wien) 146:27-35, 2004.
39. Pinto A, Tuttolomondo A, Di Raimondo D, Fernandez P, Licata G: Cerebrovascular risk factors and clinical classification of strokes. Semin Vasc Med 4:287-303, 2004.
40. Pouratian N, Sheehan J, Jagannathan J, Laws ER Jr, Steiner L, Vance ML: Gamma knife radiosurgery for medically and surgically refractory prolactinomas. Neurosurgery 59:255-266, 2006.
41. Randeva HS, Schoebel J, Byrne J, Esiri M, Adams CB, Wass JA: Classical pituitary apoplexy: Clinical features, management and outcome. Clin Endocrinol (Oxf) 51:181-188, 1999.
42. Rees DA, Hanna FW, Davies JS, Mills RG, Vafidis J, Scanlon MF: Long-term follow-up results of transsphenoidal surgery for Cushing's disease in a single centre using strict criteria for remission. Clin Endocrinol (Oxf) 56:541-551, 2002.
43. Semple PL, Webb MK, de Villiers JC, Laws ER Jr: Pituitary apoplexy. Neurosurgery 56:65-73, 2005.
44. Shimon I, Ram Z, Cohen ZR, Hadani M: Transsphenoidal surgery for Cushing's disease: Endocrinological follow-up monitoring of 82 patients. Neurosurgery 51:57-62, 2002.
45. Smith MV, Laws ER Jr: Magnetic resonance imaging measurements of pituitary stalk compression and deviation in patients with nonprolactin- secreting intrasellar and parasellar tumors: Lack of correlation with serum prolactin levels. Neurosurgery 34:834-839, 1994.
46. Toogood AA: Endocrine consequences of brain irradiation. Growth Horm IGF Res 14 [Suppl A]:S118-S124, 2004.
47. Trainer PJ, Eastment C, Grossman AB, Wheeler MJ, Perry L, Besser GM: The relationship between cortisol production rate and serial serum cortisol estimation in patients on medical therapy for Cushing's syndrome. Clin Endocrinol (Oxf) 39:441-443, 1993.
48. Webb SM, Rigla M, Wägner A, Oliver B, Bartumeus F: Recovery of hypopituitarism after neurosurgical treatment of pituitary adenomas. J Clin Endocrinol Metab 84:3696-3700, 1999.
49. Zada G, Kelly DF, Cohan P, Wang C, Swerdloff R: Endonasal transsphenoidal approach for pituitary adenomas and other sellar lesions: An assessment of efficacy, safety, and patient impressions. J Neurosurg 98:350-358, 2003.
50. Zada G, Liu CY, Fishback D, Singer PA, Weiss MH: Recognition and management of delayed hyponatremia following transsphenoidal pituitary surgery. J Neurosurg 106:66-71, 2007.